NCT00611351 2023-10-23Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerUniversity of NebraskaPhase 2 Completed5 enrolled 10 charts
NCT00450983 2017-05-24Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesFred Hutchinson Cancer CenterPhase 2 Terminated1 enrolled 5 charts
NCT00410657 2010-05-14Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled